These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14682273)

  • 1. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). New CCR5 antagonist shows antiretroviral effect.
    Feinberg J
    AIDS Clin Care; 2003 Nov; 15(11):94-5. PubMed ID: 14682273
    [No Abstract]   [Full Text] [Related]  

  • 2. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). T-1249 for T-20 salvage.
    Feinberg J
    AIDS Clin Care; 2003 Nov; 15(11):95-6. PubMed ID: 14682275
    [No Abstract]   [Full Text] [Related]  

  • 3. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Single agent therapy for HIV infection?
    Currier J
    AIDS Clin Care; 2003 Nov; 15(11):96. PubMed ID: 14682276
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-HIV agents. Introduction to ICAAC: selected highlights from the 43rd annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
    TreatmentUpdate; 2003 Oct; 15(6):1-2. PubMed ID: 17216859
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting chemokine receptors for HIV: past, present and future.
    Fricker SP
    Future Med Chem; 2015; 7(17):2311-5. PubMed ID: 26627446
    [No Abstract]   [Full Text] [Related]  

  • 6. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Suboptimal response to once-daily abacavir + 3TC + tenofovir.
    Feinberg J
    AIDS Clin Care; 2003 Nov; 15(11):94. PubMed ID: 14682272
    [No Abstract]   [Full Text] [Related]  

  • 7. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Prognosis after triple-class failure.
    Currier J
    AIDS Clin Care; 2003 Nov; 15(11):95. PubMed ID: 14682274
    [No Abstract]   [Full Text] [Related]  

  • 8. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Abacavir as initial therapy and as a once-daily drug.
    Sax PE
    AIDS Clin Care; 2003 Nov; 15(11):93-4. PubMed ID: 14682271
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.
    Soulié C; Marcelin AG; Ghosn J; Amellal B; Assoumou L; Lambert S; Duvivier C; Costagliola D; Katlama C; Calvez V
    AIDS; 2007 Oct; 21(16):2243-5. PubMed ID: 18090053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highlights from the 2001 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
    Proj Inf Perspect; 2002 Mar; (34):10-1. PubMed ID: 12038298
    [No Abstract]   [Full Text] [Related]  

  • 11. Meeting notes from ICAAC. Prevalence and predictors of R5 and X4 tropism.
    Feinberg J
    AIDS Clin Care; 2005 Jan; 17(1):7. PubMed ID: 15717374
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolution of coreceptor utilization to escape CCR5 antagonist therapy.
    Zhang J; Gao X; Martin J; Rosa B; Chen Z; Mitreva M; Henrich T; Kuritzkes D; Ratner L
    Virology; 2016 Jul; 494():198-214. PubMed ID: 27128349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meeting notes from ICAAC. Promising early results for a novel CCR5 antagonist.
    Feinberg J
    AIDS Clin Care; 2005 Jan; 17(1):8. PubMed ID: 15717376
    [No Abstract]   [Full Text] [Related]  

  • 14. Report from the 17th Conference on Retroviruses and Opportunistic Infections. CCR5 antagonists--out with the old, in with the new?
    Albrecht H
    J Watch AIDS Clin Care; 2010 Apr; 22(4):32. PubMed ID: 20480620
    [No Abstract]   [Full Text] [Related]  

  • 15. After Toronto, 46th ICAAC offers back to basics.
    Alcorn K; Bernard EJ; Carter M; Legge A; Mascolini M; Thaczuk D
    IAPAC Mon; 2006 Oct; 12(10):354-65. PubMed ID: 17390499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV chemokine receptor inhibitors as novel anti-HIV drugs.
    Princen K; Schols D
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICAAC newspaper headlines misleading on protease inhibitor failure.
    James JS
    AIDS Treat News; 1997 Oct; (No 281):1-2. PubMed ID: 11364792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 co-receptor usage based on V3 loop sequence analysis: preferential suppression of CXCR4 virus post HAART?
    Jiao Y; Wang P; Zhang H; Zhang T; Zhang Y; Zhu H; Wu H
    Immunol Invest; 2011; 40(6):597-613. PubMed ID: 21513481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report from the XVI International AIDS Conference. CCR5 inhibitors.
    Feinberg J
    AIDS Clin Care; 2006 Nov; 18(11):100-1. PubMed ID: 17186581
    [No Abstract]   [Full Text] [Related]  

  • 20. Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc.
    Cascajero A; Rastrojo A; Díez-Fuertes F; Hernández-Novoa B; Aguado B; Moreno S; Alcami J; Pérez-Olmeda M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.